Radio and PodcastRadio and PodcastLive Radio & Podcasts
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation artwork
Science & Medicine

Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation

Biotech 2050 Podcast by Biotech2050 Podcast

Feb 10, 202600:26:40Science & Medicine

Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, to Biotech 2050 for a powerful conversation at the intersection of personal mission, platform biology, and rare-disease drug dev...

About This Episode

Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, t...

Podcast

This episode belongs to Biotech 2050 Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Feb 10, 2026, 00:26:40 long, audio available.

Related Episodes

Continue listening to more episodes from Biotech 2050 Podcast.